Results 251 to 260 of about 3,631,955 (312)

A multicentre analysis of efficacy, safety and molecular response correlates of fostamatinib in warm autoimmune haemolytic anaemia and Evans syndrome

British Journal of Haematology, EarlyView.
Fostamatinib had 46% durable response, with 73% steroid reduction, in this multicentre retrospective study of refractory wAIHA/ES. Hypertension, gastrointestinal (GI) distress and neutropenia occurred in 23%. Only one patient required drug discontinuation and one patient dose reduction.
Jorge N. Ruiz Lopez, Lipei Shao, Debbie Jiang, Lawrence S. Bailey, Thejaswi Bikkani, Aaron Boothby, Donald C. Moore, Irina Murakhovskaya, Caroline I. Piatek, Mauricio Pineda‐Roman, Ping Jin, Jacqueline N. Poston, Moritz Stolla, David F. Stroncek, Krystalyn E. Hudson, James B. Bussel, Sandhya R. Panch   +16 more
wiley   +1 more source

[Secondary immunodeficiency and infection].

Nihon saikingaku zasshi. Japanese journal of bacteriology, 1982
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Overview of secondary immunodeficiency

Allergy and Asthma Proceedings
In contrast to inborn errors of immunity (IEI), which are inherited disorders of the immune system that predispose to infections, malignancy, atopy, and immune dysregulation, secondary immunodeficiencies and immune dysregulation states (SID) are acquired impairments in immune cell function and/or regulation, and may be transient, reversible, or ...
Katherine E, Herman, Katherine L, Tuttle
openaire   +3 more sources

Secondary immunodeficiency in lymphoproliferative malignancies

Hematological Oncology, 2016
AbstractSecondary immunodeficiencies occur as a consequence of various diseases, including hematological malignancies, and the use of pharmacological therapies, such as immunosuppressive, anti‐inflammatory, and biological drugs. Infections are the main cause of morbidity and mortality in multiple myeloma (MM) and chronic lymphocytic leukemia (CLL ...
Friman, V, Winqvist, O, Blimark, C, Langerbeins, P, Chapel, H, Dhalla, F   +5 more
openaire   +4 more sources

Immunodeficiency secondary to biologics

Journal of Allergy and Clinical Immunology, 2023
Roxane Labrosse, Elie Haddad
openaire   +4 more sources

Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives.

Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis, 2023
Secondary immunodeficiency (SID) can occur as a result of multiple factors, including hematological malignancies, hematopoietic stem cell transplantation (HSCT), immunosuppressive treatment, biologics, and anti-inflammatory drugs.
M. Ar, Riad El Fakih, S. Gabbassova, A. Alhuraiji, F. Nasr, Ahmad S. Alsaeed, N. Sayınalp, M. Marashi   +7 more
semanticscholar   +1 more source

[Primary and secondary immunodeficiencies].

Therapeutische Umschau. Revue therapeutique, 2014
Primary Immunodeficiencies (PID) are rare, genetically determined diseases that cause dysfunctional immunity, clinically presenting as susceptibility to infection but also as autoimmunity due to deficient immune tolerance. More than 180 PID have been described to date.
Nathan, Cantoni, Mike, Recher
openaire   +3 more sources

Secondary Immunodeficiencies of Horses

Veterinary Clinics of North America: Equine Practice, 2000
FPT of immunoglobulin in foals is the commonest form of acquired immunodeficiency in horses. FPT predisposes foals to bacterial infections and septicemia and easily is preventable and treatable if breeding farms and veterinarians are attentive to optimum foaling management practices.
openaire   +2 more sources

Immunodeficiency III: secondary immunodeficiency and AIDS

2013
This chapter concentrates on the defects in secondary immunodeficiencies and its principal causes. It emphasizes that secondary immunodeficiency results from some influence external to the immune system-infection, malnutrition, etc-ranging from the slightly increased risk of infection following surgery to the severe and progressive immune failure of ...
John H.L. Playfair, Gregory J. Bancroft
openaire   +1 more source